FDA, NIH initiative aims to speed development of drugs for ALS, other brain diseases

The Food and Drug Administration and National Institutes of Health launched a public-private initiative focused on better understanding rare brain conditions such as amyotrophic lateral sclerosis and developing new medicines for them.